The effect of hepatobel capsules in the treatment of fatty liver

Phase 3

Recruiting

• Conditions: Patients with fatty liver.; Fatty (change of) liver, not elsewhere classified; K76.0

• Registration Number: IRCT20141027019705N3
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not having known heart disease
Not having known kidney disease
Having abnormal liver parameters
Having aged 20 to 60 years.

Exclusion Criteria

Unwilling to continue study
Find sensitivity to hepatobel capsules

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improving liver function. Timepoint: Measurement of lipid profile and oxidative stress indices in the beginning of the study (before the start of the study) and 6 weeks after the intervention. Method of measurement: Measuring lipid profile and oxidative stress indices using biochemical kits.

Secondary Outcome Measures

Name	Time	Method
Improving lipid profile. Timepoint: Measurement of lipid profile in the beginning of the study (before the start of the study) and 6 weeks after the intervention. Method of measurement: Measuring lipid profile using biochemical kits.;Improving oxidative stress indices. Timepoint: Measurement of oxidative stress in the beginning of the study (before the start of the study) and 6 weeks after the intervention. Method of measurement: Measuring oxidative stress using biochemical kits.